Adam Crystal, See Remarks at Tango Therapeutics, Inc. (TNGX), sold 14,283 shares at $3.16 ($44K) on 2025-02-05, disclosed to the SEC on 2025-02-06.
Open-market sale of $44k TNGX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 7,432 | $22K | 50.7% |
| 2 | $3.16 | 6,851 | $22K | 49.3% |
| Total | $3.07 avg | 14,283 | $44K | 100% |
| Filing → |
| TNGX | SELL | 2026-08-05 | $736K | — | Filing → |
| TNGX | SELL | 2026-07-02 | $799K | — | Filing → |
| TNGX | SELL | 2026-06-03 | $618K | — | Filing → |